Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market to Surpass US$ 4,984.58 Million by 2028 | Pfizer Inc
August 12, 2022 0Middle East Logistics News
Transthyretin Amyloidosis (ATTR) is a progressive and severe orphan disease.
SEATTLE, WASHINGTON, UNITED STATES, August 12, 2022 /EINPresswire.com/ — Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market report studies the …
Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Treatment Market to Surpass US$ 4,984.58 Million by 2028 | Pfizer Inc